SCHEMBL5220608

SCHEMBL5220608

CC(COc1ccc(C=O)cc1OCc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 1/20 0.52
ALDH1A1 P00352 6/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
KDM4E B2RXH2 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 3/20 0.47
HPGD P15428 2/20 0.47
GSK3B P49841 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.46
MAPT P10636 3/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
UBE2N P61088 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
APP P05067 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5220602 1.00 TACR2 (0.52) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL6984698 0.89 AKR1C3 (0.49) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL6984701 0.89 AKR1C3 (0.49) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL3722886 0.88 TACR2 (0.55) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL7255418 0.88 FDPS (0.47) ALDH1A1SMN1; SMN2LMNAHTTHPGD
SCHEMBL7258826 0.88 FDPS (0.47) ALDH1A1SMN1; SMN2LMNAHTTHPGD
SCHEMBL7255620 0.85 ALDH1A1 (0.51) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL7255617 0.85 ALDH1A1 (0.51) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL7255613 0.85 ALDH1A1 (0.51) TACR2ALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL584489 0.85 TACR2 (0.62) TACR2ALDH1A1SMN1; SMN2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313471-B1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS UCB SA (BE) 2007-04-11 EP disclosed
US-7105554-B2 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2006-09-12 US disclosed
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD (GB) 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents SLC5A2, OXSR1, SLC5A1 TACR2 960/4885ALDH1A1 2757/4885SMN1; SMN2 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.